🔎 Trials Near Me

Home › Myocardial Ischemia › Texas

Myocardial Ischemia clinical trials in Texas

7 studies for Myocardial Ischemia are looking for participants at sites in Texas.

Cities in Texas

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

  • Texas Cardiac Arrhythmia Research Foundation, Austin
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 29, 2026 · NCT07585968

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

  • University of Texas Southwestern Medical Center, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 20 to 80 · All sexes · Updated Sep 11, 2026 · NCT06047028

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

  • Texas Cardiac Arrhythmia Research Foundation, Austin
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

  • Houston Methodist Hospital, Houston
Recruiting
Ages 35 to 85 · All sexes · Updated Sep 1, 2026 · NCT06854458

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

  • Texas Cardiac Arrhythmia Research Foundation, Austin
  • South Heart Clinic, Weslaco
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

  • The Texas Heart Institute Houston Texas, Houston
RecruitingPhase 2
Ages 21 to 85 · All sexes · Updated May 13, 2026 · NCT06145035

DeBakey Cardiovascular Magnetic Resonance Study

  • Houston Methodist Hospital, Houston
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Apr 20, 2026 · NCT04281823

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.